We have demonstrated that kallistatin gene delivery can be achieved by systemic administration of lentiviral vectors carrying kallistatin gene and the gene expression can inhibit tumor growth and enhance survival in established metastatic murine lung tumor models. This evidence concerns the gene SERPINA4 and neoplasm.